Afficher la couverture 'Faecal incontinence in inflammatory bowel disease: The Nancy experience | Kurt, Simon' en grand format
/5

0 avis

Faecal incontinence in inflammatory bowel disease: The Nancy experience

Archive ouverte

Kurt, Simon | Caron, Bénédicte | Gouynou, Celia | Netter, Patrick | Vaizey, Carolynne | Wexner, Steven | Danese, Silvio | Baumann, Cédric | Peyrin-Biroulet, Laurent

Edité par CCSD ; Elsevier -

International audience. Faecal incontinence (FI) is a disabling condition in patients with inflammatory bowel disease (IBD). The diagnosis of FI is not easy as patients are reluctant to report this embarrassing symptom. The objectives of this study were to characterize the prevalence of FI in IBD patients using available scoring systems, and to identify associated risk factors.

Consulter en ligne

Suggestions

Du même auteur

Inflammatory Bowel Disease Patients’ Acceptance for Switching from Intravenous Infliximab or Vedolizumab to Subcutaneous Formulation: The Nancy Experience

Archive ouverte | Remy, Clotilde | CCSD

International audience. Background: Subcutaneous infliximab and vedolizumab formulations have been developed for maintenance therapy in inflammatory bowel disease. The objective of this study was to explore the infl...

Ocular Manifestations in Patients with Inflammatory Bowel Disease in the Biologics Era

Archive ouverte | Cuny, Alix | CCSD

International audience. Background: Extra-intestinal manifestations are frequent in inflammatory bowel disease (IBD). Ocular disorders are generally under diagnosed as they are challenging diagnosis. Aims: We assess...

I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease

Archive ouverte | Peyrin-Biroulet, Laurent | CCSD

International audience. There is a need to evaluate the benefit-risk ratio of current therapies in inflammatory bowel disease (IBD) patients to provide the best quality of care. The primary objective of I-CARE (IBD ...

Chargement des enrichissements...